Drug-Drug Interaction (DDI) Study for TQB3616

• Status: NOT_YET_RECRUITING
• Trial end date: 2025-07-01

Summary

To evaluate the effect of itraconazole/rifampicin on the pharmacokinetics of TQB3616 capsules.

To assess the safety of a single dose of oral TQB3616 capsules and in combination with itraconazole/rifampicin.

• Phase: PHASE1

Details

• Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
• Treatments: Itraconazole; Rifampin